Quantum-Si (NASDAQ:QSI) Announces Earnings Results

Quantum-Si (NASDAQ:QSI) announced its earnings results on Tuesday. The company reported ($0.18) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.03, reports. Quantum-Si had a negative net margin of 3,968.84% and a negative return on equity of 35.42%. The firm had revenue of $0.79 million for the quarter, compared to analyst estimates of $1.06 million.

Quantum-Si Price Performance

Shares of QSI opened at $0.79 on Thursday. The firm has a 50 day simple moving average of $0.86 and a two-hundred day simple moving average of $1.12. The company has a market cap of $112.65 million, a P/E ratio of -1.24 and a beta of 2.89. Quantum-Si has a one year low of $0.70 and a one year high of $2.43.

Institutional Trading of Quantum-Si

Several large investors have recently bought and sold shares of QSI. Jacobs Levy Equity Management Inc. bought a new stake in shares of Quantum-Si during the first quarter worth $998,000. Vanguard Group Inc. grew its position in Quantum-Si by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 5,300,685 shares of the company’s stock worth $10,442,000 after acquiring an additional 82,463 shares during the last quarter. SG Americas Securities LLC acquired a new position in Quantum-Si in the 3rd quarter worth about $53,000. Virtu Financial LLC bought a new position in Quantum-Si in the first quarter valued at about $98,000. Finally, Green Alpha Advisors LLC boosted its stake in shares of Quantum-Si by 35.4% during the third quarter. Green Alpha Advisors LLC now owns 175,055 shares of the company’s stock valued at $154,000 after purchasing an additional 45,796 shares in the last quarter. 39.90% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on QSI shares. Canaccord Genuity Group reduced their price target on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Wednesday. HC Wainwright restated a “buy” rating and issued a $4.00 price target on shares of Quantum-Si in a research report on Wednesday.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.